COGT vs DFTX Stock Comparison

DFTX currently leads COGT in this stock comparison, with AIQ scores of 59 vs 44. The clearest difference is quality, while COGT has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 15 points
COGT
Healthcare
vs
DFTX
Healthcare
COGT
Cogent Biosciences, Inc.
Price
$28.56
Day move
-1.99%
AIQ Score
44/100
Best edge
Risk Resilience
Sector
Healthcare
DFTX
Definium Therapeutics, Inc.
Leads
Price
$32.08
Day move
-2.79%
AIQ Score
59/100
Best edge
Quality
Sector
Healthcare

What is the main difference between COGT and DFTX?

DFTX leads the current stock comparison as Definium Therapeutics, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Cogent Biosciences, Inc. vs Definium Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 59/66 fields· Moderate confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 7/10

DFTX leads

DFTX leads by 15 AIQ points, primarily on Quality and Momentum, but the lead has narrowed from 18 points over 30 sessions.

Competitive: 3 of 4 evidence groups support DFTX, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 3 of 4Comparison trend: Weakening
COGT

Cogent Biosciences, Inc.

AIQ Score
44/100
AIQ Edge Score
7/10
DFTX

Definium Therapeutics, Inc.

Leads
AIQ Score
59/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors DFTX over COGT, 59 versus 44 as of Nov 15, 2026. DFTX's advantage is driven primarily by stronger quality and momentum, while COGT holds the stronger risk resilience profile. DFTX also shows the weaker technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor DFTX today, and the comparison is rated Competitive on stability: the leader's advantage has been narrowing. DFTX lead: Weakening — the AIQ differential moved from 18 to 15 points over 30 sessions.

Compare Cogent Biosciences, Inc. and Definium Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

COGT
+164.2%
DFTX
-4.5%

Price return comparison

Growth of $10,000, price only

COGT $26,420 · DFTX $9,548

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare COGT and DFTX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

COGT advantage
0
DFTX advantage
  • Quality40 vs 60
    DFTX +20
  • Momentum45 vs 64
    DFTX +19
  • Risk Resilience51 vs 44
    COGT +7

3 of 4 evidence groups favor DFTX. DFTX’s edge is concentrated in quality and momentum; COGT keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

COGT+1 AIQ

Largest factor move: Momentum +3

New signals

  • 52-Week Low Proximity — bearish, risk_regime, long horizon (2.6%)
DFTX+1 AIQ

No factor moved materially.

New signals

  • MACD Bearish Crossover — bearish, momentum, short horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon

DFTX's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — COGT and DFTX both carry a full feed there.

The central trade-off

DFTX (Definium Therapeutics, Inc.): the stronger current systematic profile, led by quality and momentum.

COGT (Cogent Biosciences, Inc.): the counter-case, on risk resilience.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

DFTX

DFTX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

DFTX

DFTX on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

DFTX

DFTX on the Momentum factor, by 19 points.

Lower downside

COGT

COGT on Risk Resilience, by 7 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureCOGTDFTXNote
Implied upside to target—+135.3%Level
Target dispersion—+11.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1219Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 4 covered evidence groups favor DFTX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreDFTX44 vs 59
FundamentalsDFTXrevenue growth 0% vs 0%; EPS growth -13.5% vs 74.3%; TTM ROE -21.6% vs -5.3%; gross margin 0% vs 0%; operating margin 0% vs 0%
ValuationNot coveredNot covered
TechnicalsDFTXPrice vs 50-day -9% vs -11.1%; vs 200-day -19.1% vs 5.4%
Risk ResilienceCOGTRisk Resilience 51 vs 44
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of COGT and DFTX and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 15 points. (supports the conclusion holding)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on DFTX.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

DFTX lead: Weakening — the AIQ differential moved from 18 to 15 points over 30 sessions.

May 27COGT leads above the line · DFTX leads belowNov 13
Today
DFTX +15
44 vs 59
7 sessions ago
DFTX +15
43 vs 58
30 sessions ago
DFTX +18
40 vs 58
90 sessions ago
DFTX +17
55 vs 72

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

COGT

0 bullish / 4 bearish / 2 neutral

Only COGT

  • Death Cross Active — bearish, trend, long horizon (12.45%)
  • 52-Week Low Proximity — bearish, risk_regime, long horizon (2.6%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • Downtrend Structure Active — bearish, trend, long horizon
DFTXConflicted

1 bullish / 3 bearish / 1 neutral, conflicted

Only DFTX

  • Golden Cross Active — bullish, trend, long horizon (18.54%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • MACD Bearish Crossover — bearish, momentum, short horizon

Both carry 2 more signals that do not separate them: ATR Expansion - Breakout Mode, MACD Histogram Expanding Bearish.

DFTX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

COGTDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -1.99%, AIQ +1 points).

DFTXDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -2.79%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1COGT closes the Quality gap — currently 20 points behind, the largest single contributor to DFTX's edge.
  2. 2COGT's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3DFTX's conflicting signal state resolves bearish — it currently carries 1 bullish and 3 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 15-point move would eliminate DFTX's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

DFTX leads on balance
MetricCOGTDFTX
Revenue growth (YoY)0%0%
EPS growth (YoY)-13.5%74.3%
Gross margin0%0%
Operating margin0%0%
Return on equity (TTM)-21.6%-5.3%
Debt to equity0.470.04

Performance

DFTX leads 5 of 6 windows
MetricCOGTDFTX
1 week (5 sessions)-9.7%-3.6%
1 month (20 sessions)-3.3%-0.1%
3 months (63 sessions)-24.6%-29.1%
6 months (126 sessions)-12.6%52.8%
Year to date-19.6%139.6%
1 year (252 sessions)-19%164.3%

Technicals

DFTX has the stronger structure
MetricCOGTDFTX
RSI (14)40.841.6
ADX (14)17.515
Price vs 50-day-9%-11.1%
Price vs 200-day-19.1%5.4%
Volatility (1M, annualized)62.1%75.9%

Risk

COGT is the more resilient
MetricCOGTDFTX
Beta1.381.14
Sharpe ratio-0.231.61
Sortino ratio-0.333.34
Max drawdown-34.4%-37.3%
Current drawdown-33.3%-33.8%
Annualized volatility46%77.7%
Value at risk (95%)-4.5%-5.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, COGT or DFTX?

On the Algovestiq AIQ Score, DFTX is the stronger of the two as of Nov 15, 2026, scoring 59 against COGT's 44. The edge comes from quality and momentum. COGT is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is COGT or DFTX the better buy right now?

DFTX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 4 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor DFTX over COGT?

The composite weights Quality, Value, Momentum and Risk Resilience. DFTX leads Quality by 20 points; DFTX leads Momentum by 19 points; COGT leads Risk Resilience by 7 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, COGT or DFTX?

Analyst price targets imply not covered upside for COGT and +135.3% for DFTX. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, COGT or DFTX?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, COGT or DFTX?

DFTX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, COGT or DFTX?

DFTX on the Momentum factor, by 19 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, COGT or DFTX?

COGT is the more resilient of the two, so the other name carries the higher downside risk. COGT on Risk Resilience, by 7 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is COGT more profitable than DFTX?

DFTX leads on the comparable margin measures — gross margin 0% vs 0%; operating margin 0% vs 0%; ttm roe -21.6% vs -5.3%.

Is DFTX's lead over COGT getting stronger or weaker?

DFTX lead: Weakening — the AIQ differential moved from 18 to 15 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the COGT vs DFTX verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: COGT closes the Quality gap — currently 20 points behind, the largest single contributor to DFTX's edge; COGT's Death Cross Active resolves — a bearish trend rule currently active against it; DFTX's conflicting signal state resolves bearish — it currently carries 1 bullish and 3 bearish rules at once; the narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 15-point move would eliminate DFTX's advantage entirely.

What do the current signals say about COGT and DFTX?

COGT: 0 bullish / 4 bearish / 2 neutral. DFTX: 1 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on COGT is Death Cross Active (bearish, long horizon). On DFTX it is Golden Cross Active (bullish, long horizon).

Compare COGT and DFTX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.